Vote Scores

Home / Companies / Atara Biotherapeutics, Inc. / 10 Jun 2024

Meeting · year to 30 June 2024142 filers reporting

Atara Biotherapeutics, Inc.: meeting of 10 Jun 2024

Votes reported on Form N-PX, item by item

142 Form N-PX filers reported votes at the Atara Biotherapeutics, Inc. meeting of 10 Jun 2024. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 81.8% of reported votes for; 20 filers withheld from or voted against at least one nominee.

194 vote records from 51 filers. 1 of the 50 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

64.7% for0.0% against35.3% other2.0% against management51 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

206 vote records from 142 filers. 11 of the 135 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.

0 filers reported share counts too large to be the holding described. No share split is published for this item. How that is decided

87.3% for7.7% against4.9% other8.1% against management142 filers
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

97 vote records from 51 filers. 0 of the 50 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

0 filers reported share counts too large to be the holding described. No share split is published for this item. How that is decided

98.0% for0.0% against2.0% other0.0% against management51 filers
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

106 vote records from 51 filers. 0 of the 50 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

98.0% for0.0% against2.0% other0.0% against management51 filers100.0% for0.0% against0.0% against management17,428,218 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

282 vote records from 51 filers. 25 of the 50 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

43.1% for49.0% against7.8% other50.0% against management51 filers63.7% for36.3% against36.3% against management47,196,106 reported shares, counted once per item in this group
6

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

97 vote records from 51 filers. 9 of the 50 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

80.4% for17.6% against2.0% other18.0% against management51 filers72.7% for27.3% against27.3% against management16,156,081 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalNo reportAgainst *No report
State Street and SPDRForForFor
InvescoNo reportAgainst *No report
EquitableForForFor
Charles SchwabForForFor
ProShares and ProFundsSplit or no voteForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForAgainst *For
J.P. MorganForForFor
Goldman SachsNo reportForNo report
PGIM and PrudentialNo reportForNo report
Northern Trust and FlexSharesNo reportForNo report
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaSplit or no voteForFor
NationwideForForFor
Guggenheim and RydexSplit or no voteForFor
BNY MellonNo reportForNo report
PrincipalSplit or no voteForFor
Pacific Life fundsForForFor
Global XForForFor
AllianceBernsteinNo reportForNo report
DWSSplit or no voteForFor
Janus HendersonNo reportForNo report
Neuberger BermanNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Atara Biotherapeutics, Inc. meeting?

142 Form N-PX filers reported votes at the meeting of 10 Jun 2024. On say-on-pay, 11 of 135 voted against management (8.1%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Atara Biotherapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Atara Biotherapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Atara Biotherapeutics, Inc. with a meeting date within three days of 10 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.